Hybrid


Detecting and Preventing Cancer

Field Willingham is working to halt the progress of esophageal conditions before they become malignant, using therapies that are minimally invasive.


Hybrid Cancer Drug Could Be Resistance-Resistant
A team of cancer researchers led by scientists at UC San Francisco and Memorial Sloan Kettering Cancer Center demonstrated in human cells and mouse models that a first-of-its-kind hybrid drug can outsmart drug-resistant cancers.

  • Unraveling Mechanisms of Drug Resistance in Common Cancer Pathway
  • Hybrid Drug Prevents Resistance in Human Cells, Mice

Share your information about Hybrid Cancer Treatments!